Research programme: HIV gp41 inhibitors - Whitehead Institute for Biomedical Research/Howard HughesAlternative Names: D-peptide inhibitors; HIV gp42 inhibitors - Whitehead Institute/Hughes Medical Institute/Massachusetts Insitute of Technol; IQN17
Latest Information Update: 30 Apr 2002
At a glance
- Originator Nonindustrial sources
- Mechanism of Action HIV envelope protein gp41 inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported HIV infections